CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at 11:00 a.m. PST (2:00 p.m. EST).

The presentation will be webcast live and may be accessed from 'Events & Presentations' on the home page of Vertex's website at . A replay of the webcast will also be available on the Company's website for two weeks following the presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.

Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 1,900 employees around the world, and Science magazine named Vertex number one on its 2011 list of Top Employers in the life sciences.

.

(VRTX-WEB)

Vertex Pharmaceuticals
Lora Pike, 617-444-6755
Director, Investor Relations

Source: Vertex Pharmaceuticals Incorporated

News Provided by Acquire Media

distribué par

Ce noodl a été diffusé par Vertex Pharmaceuticals Incorporated et initialement mise en ligne sur le site http://www.vpharm.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-04 15:05:40 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.